U.S. Human Growth Hormone Market Size Worth USD 4.35 Billion by 2034 | CAGR: 7.8%

The U.S. human growth hormone market size is expected to reach USD 4.35 Billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Human Growth Hormone Market Size, Share, Trends, Industry Analysis Report: By Type (Long-acting, Short-acting & Intermediate-acting), By Route of Administration, By Age, By Disease, By Distribution Channel– Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human growth hormone is a protein hormone produced by the pituitary gland that stimulates growth, cell reproduction, and regeneration in humans. It plays a crucial role in childhood growth and continues to regulate body composition, muscle and bone growth, and metabolism in adults.

The rise of telemedicine and online pharmacies in the U.S. is making it easier for patients to access and manage hGH treatments. Virtual consultations help speed up diagnosis and prescription processes, especially in remote or underserved areas. Online pharmacies offer convenient, discreet delivery of hGH products, improving patient adherence and reducing drop-offs. This digital transformation was accelerated by the COVID-19 pandemic and is now a lasting trend in U.S. healthcare. These channels are becoming a major driver of growth in the U.S. hGH demand with regulatory support and growing consumer trust in e-health platforms, thereby fueling the industry growth.

Bottom of Form

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-human-growth-hormone-market/request-for-sample

The U.S. hGH market is seeing growing demand among adults with hormone deficiencies. Conditions like adult growth hormone deficiency (AGHD), age-related hormone decline, and muscle-wasting disorders are now more commonly treated with hGH. Increased awareness, greater diagnostic accuracy, and expanding clinical guidelines are all contributing to this shift. Many adults are seeking hGH therapy to improve energy, bone health, and physical performance. More endocrinologists are specializing in adult hormone therapy and insurance providers are broadening coverage further fueling the demand for human growth hormone, thereby driving the market growth.

U.S. Human Growth Hormone Market Report Highlights

• The long-acting segment is projected to grow at a CAGR of 8.4% during the forecast period, driven by its ease of use and improved patient adherence compared to daily injections.
• The oral segment is expected to capture a notable market share in the coming years, fueled by rising demand for non-invasive treatment alternatives.
• In 2024, the adult segment accounted for 54.64% of the market revenue, supported by growing awareness of adult growth hormone deficiency and related symptoms like fatigue, weight gain, and low bone density.
• The online pharmacies segment held a 14.26% revenue share in 2024, as e-pharmacies emerge as a key distribution channel in the U.S. market, offering patients greater convenience, privacy, and faster delivery of hGH treatments.
• The key market players in U.S. are AnkeBio Co., Ltd; Ascendis Pharma; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Ferring Pharmaceuticals; Merck KGaA; Novo Nordisk A/S; Pfizer Inc; Sandoz Inc.; Teva Pharmaceuticals USA, Inc.

Polaris market research has segmented the U.S. Human Growth Hormone Market report based on type, route of administration, age, disease, distribution channel:

By Type (Revenue - USD Billion, 2020–2034)

• Long-acting
• Short-acting & Intermediate-acting

By Route of Administration (Revenue - USD Billion, 2020–2034)

• Oral
• Parenteral
  • Intravenous
  • Subcutaneous
  • Intramuscular

By Age (Revenue - USD Billion, 2020–2034)

• Pediatric
• Adult

By Disease (Revenue - USD Billion, 2020–2034)

• Growth Hormone Deficiency
  • Pediatric GHD
  • Adult GHD
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Others

By Distribution Channel (Revenue - USD Billion, 2020–2034)

• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies